Related Experiment Video
Updated: May 15, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Hypovitaminosis d: a contributor to psychiatric disorders in elderly?
Jennifer Ford1, Ana Hategan, James A Bourgeois
1Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON;
Background:
Hypovitaminosis D is unrecognized and remarkably common in geriatric patients, with various clinical manifestations. The purpose of this study was to prospectively assess the vitamin D (VD) status in newly admitted psychogeriatric patients, and to study the correlation of VD status with indicators of calcium metabolism.
Methods:
A valid VD sample, as measured by serum 25-hydroxyvitamin D (25-OHD), was obtained from nine consecutive psycogeriatric inpatients (66% women), during a one-month period in 2011. The Research Ethics Boards at St. Joseph's Healthcare Hamilton approved this project.
Results:
All participants showed VD inadequacy (defined as 25-OHD ≤ 75 nmol/L) with a mean level of serum 25-OHD of 45.5 ± 14.6 (range 28.5-73.4) nmol/L. None of the patients in the sample met criteria for VD deficiency (currently defined by expert consensus as 25-OHD < 25 nmol/L). Mean serum VD levels were lower in females (38.8 ± 9.8 nmol/L) than in males (59.0 ± 14.3 nmol/L), p = .03. Magnesium and PTH were both higher in females (p = .03 and .02, respectively). Univariate linear regression analysis showed that VD levels were strongly negatively associated with magnesium (p = .001) and PTH (p = .02).
Conclusion:
Since research links VD deficiency to psychiatric conditions, high rates of insufficiency in this population is very common and routine supplements are strongly suggested, regardless of patients' living environment.
Related Concept Videos
Drug Dosing: Geriatric Patients
Vitamins
Pharmacodynamics in Geriatric Patients: Effects of Age
Dementia l: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Alzheimer Disease l: Introduction